Coronary artery disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. subjects aged 18-80 years old; 2. subjects (or legal guardian) understands the trial requirements and treatment procedures and provides written informed consent before any trial-specific tests or procedures are performed; 3. subjects is eligible for percutaneous coronary intervention (PCI); 4. subjects has Stable/unstable angina; 5. Non-infarct-related artery of subjects has STEMI>24-hour from the onset of chest pain to admission; 6. subjects is an acceptable candidate for coronary artery bypass grafting (CABG); 7. subjects is willing to comply with all protocol-required follow-up evaluations.
Exclusion criteria
Exclusion criteria: 1. Subjects with STEMI (within 24-hour from the onset of chest pain to admission); 2. Subjects suffering from atrial fibrillation; 3. Subjects has known allergy to the study stent system (everolimus) or protocol-required concomitant medications; 4. Subjects has any other serious medical illness that may reduce life expectancy to less than 12 months; 5. Subjects is a women who is pregnant or nursing; 6. Subjects has a planned procedure that may cause non-compliance with the protocol or confound data interpretation. Patient is participating in another clinical trial that has not reached its primary endpoint within 24 months after the index procedure; 7. Left main disease; 8. Severe calcification need Rotablator treatment; 9. Bridge vessels of coronary artery bypass graft (CABG).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fractional flow reservation; | — |
Countries
China